University of Nebraska Foundation Endowment

Investment Strategy

The University of Nebraska Foundation manages approximately $2.5 billion in endowment assets as of June 30, 2024, making it one of the larger public university foundations in the Midwest. The Foundation serves as the primary fundraising and endowment management organization for the University of Nebraska system, which encompasses four campuses: the University of Nebraska-Lincoln, the University of Nebraska at Omaha, the University of Nebraska at Kearney, and the University of Nebraska Medical Center. Endowment distributions support thousands of scholarships, endowed faculty positions, research programs, and campus improvements across the system.

The Foundation operates as an independent 501(c)(3) with its own board of directors and investment committee. The investment committee sets asset allocation policy and oversees an internal investment team responsible for manager selection, portfolio construction, and risk management. The portfolio follows a diversified, multi-asset approach with approximately 40% allocated to alternative investments.

Public equities, both domestic and international, form the largest liquid allocation. Fixed income and cash reserves provide stability and ensure sufficient liquidity for annual distributions and capital calls. The investment philosophy centers on long-term real return generation, seeking to preserve the endowment’s purchasing power while supporting growing distribution needs across the university system.

The Foundation’s scale provides meaningful advantages in manager access, fee negotiations, and portfolio diversification. The investment team takes a disciplined approach to manager selection, emphasizing track record, strategy differentiation, team quality, and alignment of interests. Nebraska’s strong philanthropic culture and engaged alumni base have contributed to consistent endowment growth through both investment returns and new gifts.

Private Markets Approach

Private equity and venture capital represent a significant allocation within the Foundation’s alternatives portfolio. The PE program spans buyout, growth equity, and venture capital strategies across multiple vintage years. The investment team maintains a disciplined commitment pacing strategy, deploying capital consistently to build a mature private markets portfolio.

Buyout allocations include both mid-market and upper mid-market managers, with the team favoring GPs who generate returns through operational improvement and strategic value creation. Manager selection criteria include team stability, sourcing capabilities, sector expertise, and discipline around fund size growth. Growth equity commitments target managers investing in high-growth companies with proven business models.

The venture capital allocation provides exposure to early-stage innovation, primarily in technology and life sciences. The University of Nebraska Medical Center’s research programs provide the investment team with informed perspective when evaluating healthcare-focused fund managers.

Real estate investments span value-add and opportunistic strategies across domestic markets. The allocation provides diversification, income, and inflation protection. The investment team monitors geographic concentration and evaluates managers based on market selection, asset management capabilities, and track record across cycles.

Natural resources investments include agriculture, timberland, and energy strategies. Nebraska’s agricultural economy provides the investment team with deep familiarity when evaluating farmland and agriculture-related investment opportunities. The allocation provides inflation hedging and diversification from traditional asset classes.

Hedge fund allocations include long/short equity, event-driven, and multi-strategy approaches designed to generate returns with lower public market correlation.

The Foundation evaluates co-investment opportunities selectively alongside existing GP partners, participating when conviction is high and economics improve net returns. The team’s scale and institutional sophistication make it an attractive co-investment partner for GPs seeking committed, long-term capital.